VG Ftse Eur

China Leverages New Energy Exports to Counter Economic Risks; HSBC Launches Fund as EU Considers Reducing Dependence

HSBC: Low Financing Dependence and High Deposit-Lending Ratio Grant Flexibility and Growth Potential

HSBC: AI to Reshape Finance Jobs, Group Retraining Staff to Adapt

HSBC CEO Announces Takeover of Hang Seng and Major Cost Cuts to Drive Growth

HSBC Unveils Business Strategy Update: Cuts 300 MDs in a Year, Reduces Headcount by 4,400 to Save $600M

French Anti-Fraud Officials Raid Nestle's Perrier Plant Amid Fraud Probe

HSBC Opens Fifth Wealth Centre Aiming to Become Asia's Largest Wealth Manager

HSBC Opens 4th Wealth & Health Center, Expands Mainland Medical Partnerships for High-Net-Worth Clients

HSBC prices 1.4 billion AUD senior unsecured kangaroo bonds

HSBC Holdings Raises AUD 1.4 Billion via Three-Part Kangaroo Bond Deal

HSBC Opens 5th Premier Wealth Centre in Hong Kong, Appointments Fully Booked

HSBC Holdings launches benchmark AUD bond issuance

HSBC Holdings Issues Perpetual Subordinated Contingent Convertible Securities

TotalEnergies Executive Jean Pierre Sbraire Offloads Shares Worth ~912k EUR OTC

HSBC Premier Launches First Cross-Border Health Ecosystem Covering HK and Mainland

AstraZeneca and Daiichi Sankyo's Enhertu Approved by FDA for HER2+ Early Breast Cancer

AstraZeneca's Baxfendy Approved in US, Outpacing Mineralys Therapeutics

AstraZeneca and Roche Diagnostics APAC Partner to Develop Advanced Pathology Solutions for Breast and Lung Cancer

TotalEnergies Visits GCL Photonics to Deepen Perovskite Global Cooperation

HSBC Launches $4 Billion Credit Facility to Support Chinese Enterprises' Global Expansion in Sustainable Technology

OPTIMI HEALTH CORP

HCW Biologics

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

Micware

Silexion Therapeutics

GCL Global

MetaVia

EMMIS ACQUISITION CORP. ORD USD0.0001 (S/R 12/09/2030)

HORIZON SPACE ACQUISITION II CORP COM USD0.0001 30/03/2026(SUB/RIGHTS)

Bristol-Myers Squibb Company

00005

China is leveraging its dominance in alternative energy and electric vehicles to offset economic challenges, particularly as the real estate sector falters. With exports of wind and solar equipment and electric cars reaching record highs, HSBC is launching a fund to support Chinese exporters in this sector. However, concerns arise over global dependence on China for critical components, especially as the EU considers reducing reliance on Chinese suppliers amidst geopolitical tensions.

- China has emerged as the leading sponsor and exporter of alternative energy systems and electric vehicles, helping to offset economic challenges in other sectors.  
- The country's economy is increasingly reliant on the sale of wind and solar equipment and electric cars, with significant growth in cement production due to rising exports despite a struggling real estate market.  
- Amid high demand, HSBC has launched a fund for Chinese alternative energy exporters, while concerns over reliance on China grow, particularly in Europe, which struggles to find alternative suppliers for critical components needed for energy transition.

Baystreet

HSBC HOLDINGS

HSBC

HSBC 5xShortSG241213

HSBC Holdings Plc

China Turns Green Tech Into an Economic Lifeline

HSBA

HSBH

HSBC HOLDINGS CFO Pam Kaur stated that the bank is less reliant on market funding compared to its peers, enhancing its ability to seize quality loan opportunities. The group's customer demand deposits to loans ratio stands at 124%, surpassing the APAC ratio of 122% and most competitors below 100%. This positions HSBC favorably to act quickly on high-quality lending opportunities that align with its strategy and risk appetite.

- HSBC Holdings reported a short selling figure of $ 213.24 million with a ratio of 48.867%.  
- CFO Pam Kaur stated that the Group's reliance on market financing is lower than its peers, enhancing its flexibility.  
- The Group's customer demand deposits to customer loans ratio was 124%, surpassing the HSBC APAC ratio of 122% and most peers, allowing swift action on high-quality lending opportunities.

AASTOCKS News

HSBC Holdings plc ADRhedged

CFO Pam Kaur: HSBC HOLDINGS Less Reliant on Mkt Funding Than Peers, Better Positioned to Capture Quality Loan Opportunities

OCBC has outbid competitors by over US$100 million to acquire HSBC's retail and wealth assets in Indonesia, entering bilateral negotiations for the deal. The transaction, valued based on net asset value and a premium of up to S$480 million, aims to strengthen OCBC's presence in Southeast Asia. The deal is expected to be finalized in the first half of next year, pending regulatory approvals. Analysts view the acquisition positively, anticipating it will enhance OCBC's profitability and growth in the region.

- OCBC has significantly outbid other contenders to acquire HSBC's retail and wealth assets in Indonesia, exceeding rival offers by more than US$100 million.  
- The deal, aimed at enhancing OCBC’s presence in Southeast Asia, is valued based on HSBC Indonesia's net asset value and a premium of approximately S$480 million, subject to regulatory approval.  
- This acquisition, which includes employing all 1,300 HSBC Indonesia retail staff, marks the first major move for OCBC's new CEO as the bank seeks to expand its operations in the region.

Businesstimes News

OCBC Bank

DBS Group

United Overseas Bank (UOB)

Sumitomo Mitsui Financial Group, Inc.

Sumitomo Mitsui Financial

Commonwealth Bank of Australia

OCBC outbids banks on HSBC Indonesia deal by wide margin: sources

Pentagreen Capital's Asia-focused blended finance program has secured $800 million in committed capital, with new participation from DBS and Cathay United Bank. The initiative, backed by HSBC and Temasek, aims to support sustainable infrastructure projects in Southeast and South Asia. Despite the urgent need for $1.7 trillion in annual investments to meet climate goals, challenges remain in attracting commercial financing for transition projects, as noted by industry leaders.

- Pentagreen Capital Fund Management's Asia-focused blended finance program has achieved $800 million in committed capital.  
- Singapore's DBS and Taiwan's Cathay United Bank are joining the program, aiming to support sustainable infrastructure projects constrained by capital.  
- The initiative is part of a Singapore central bank effort to finance Asia's green transition, addressing the significant investment needs of developing economies amidst challenges in attracting commercial financing.

MorningStar

HSBC, Temasek-Backed Pentagreen Capital's Finance Program Reaches $800 Million in Committed Capital

HSBC economists predict that central banks will continue to raise policy rates even if a US-Iran peace agreement is reached. They highlight ongoing risks of supply shocks affecting global inflation and growth. Central banks in Australia and Norway are already under inflationary pressure, with potential rate hikes from the European Central Bank and Bank of England in mid-year. HSBC also expects further rate increases in the Philippines, India, and Indonesia later this year.

CoinLive

HSBC Economists Predict Continued Rate Hikes Despite Potential US-Iran Peace

HSHD

HSBC has launched a $4 billion credit facility in mainland China to support the global expansion of clean energy and low-carbon industries. The facility aims to help businesses scale internationally, particularly in ASEAN, and facilitate decarbonization efforts. It will provide financing across various sectors, including clean power and electrification of transport, while enhancing Singapore's role as a key investment hub. HSBC emphasizes the importance of accessible clean-energy supply chains for transitioning to renewables and aims to assist Chinese businesses in bringing clean technologies to market efficiently.

- HSBC has launched a $4 billion Sustainability and Transition Credit Facility in mainland China to support clean energy and low-carbon businesses looking to expand internationally, particularly in ASEAN.  
- The initiative aims to foster decarbonization and is expected to enhance Singapore’s role as a key investment hub, facilitating access to renewable energy infrastructure for ASEAN nations.  
- With a growing demand for clean technologies, HSBC’s efforts include tailored financial solutions and collaborations to aid businesses in their transition to sustainable practices and technologies.

TechNode

HSBC HK SDR 5to1

HSBC launches $4B credit facility supporting global expansion of China’s low carbon industries

HSBC has launched a $4 billion credit facility to support mainland Chinese clean energy firms in their international expansion, particularly in the ASEAN region. The Sustainability and Transition Credit Facility will finance various sectors, including clean power and AI. Singapore is expected to play a key role in deploying these funds, with strong interest from Chinese companies to expand into ASEAN through the city-state, according to HSBC's Gilbert Ng.

- HSBC has launched a $4 billion credit facility aimed at helping mainland Chinese companies in clean energy and low-carbon sectors scale internationally, particularly in the ASEAN region.  
- The Sustainability and Transition Credit Facility will finance businesses in various sectors, including clean power and electrification of transport, with Singapore expected to play a key role in deploying these funds.  
- HSBC highlights strong interest from Chinese clean energy firms to enter ASEAN through Singapore, enhancing sustainable finance options and supporting the region's capital mobilization for climate action.

Singapore Business Review

HSBC deploys $4b for Chinese clean energy firms seeking overseas expansion

REGN

The FDA has granted breakthrough therapy designation to baxdrostat for uncontrolled hypertension, a significant milestone for patients. Meanwhile, the agency faces instability with leadership departures, raising concerns about regulatory consistency. Additionally, Regeneron has entered a multibillion-dollar collaboration with Parabilis Medicines to develop new therapeutic candidates using AI-driven drug discovery.

Pharmexec

Regeneron Pharma

AstraZeneca

VG Health

Invesco Biotechnology & Genome ETF

SPDR S&P Biotech

Direxion S&P Biotech Bull 3X

Proshares Ultra Nasdaq Biotech

Ark Genomic Revolution ETF

VanEck Biotech ETF

iShares Global Healthcare

iShares US Pharma

Health Care Select Sector SPDR

iShares Biotechnology ETF

ALPS Medical Breakthrough

First Trust NYSE Arca Biotech Index Fd

Invesco Nasdaq Biotechnology ETF

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Baxdrostat]]>

AstraZeneca received FDA approvals for Baxfendy, a hypertension treatment, and Enhertu for early HER2-positive breast cancer. Baxfendy targets uncontrolled hypertension, while Enhertu's approvals cover neoadjuvant and adjuvant settings. These milestones will result in $155 million payments to Daiichi Sankyo. AstraZeneca shares rose 1.56% to $184.42, despite a 9.1% decline over the past month.

Fidelity

AstraZeneca PLC

Mineralys Therapeutics

Daiichi Sankyo Company, Limited

Daiichi Sankyo

S&P 500

AstraZeneca Scores Key FDA Wins Across Cardiovascular And Oncology Portfolios

The FDA has approved Baxfendy (baxdrostat) for adults with hypertension inadequately controlled on other medications, marking the first aldosterone synthase inhibitor for this condition. The approval is based on the phase 3 BaxHTN trial, showing significant reductions in systolic blood pressure. This innovative treatment targets a root cause of uncontrolled hypertension, potentially transforming clinical practice. AstraZeneca's acquisition of Baxfendy ties it to a broader cardiorenal strategy, with future success dependent on market positioning and long-term outcomes.

<![CDATA[FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry]]>

VG Ftse Eur(VGK.US)